Binbin Cheng

Also affiliated with Lishui Central Hospital, Hubei Polytechnic University, National Center for Drug Screening, Southern Medical University, Hebei Normal University

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “HDAC-targeting epigenetic modulators for cancer immunotherapy”.

HDAC-targeting epigenetic modulators for cancer immunotherapy

European Journal of Medicinal Chemistry(2024)10.1016/j.ejmech.2024.116129

N/A

2.1DataRank · unranked

92 citations

Wei Pan, Yao Xiao, Zongbao Ding, Yingxing Zhou, Xiaoting Fei +5 more

Recent advances in DDR (DNA damage response) inhibitors for cancer therapy

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.114109

N/A

0.723DataRank · unranked

123 citations

Wei Pan, Yi Xing, Yao Xiao, Jianjun Chen, Zheng Xu +1 more